HitGen Inc. A
HitGen Inc. operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally. Its technology platform includes DNA-encoded library technology; fragment-based drug discovery and structure-based drug design technologies; emerging technology platforms for synthetic therapeutic oligonucleotide technology; and targeted protein degradation technolog… Read more
HitGen Inc. A (688222) - Total Liabilities
Latest total liabilities as of June 2025: CN¥385.43 Million CNY
Based on the latest financial reports, HitGen Inc. A (688222) has total liabilities worth CN¥385.43 Million CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
HitGen Inc. A - Total Liabilities Trend (2019–2024)
This chart illustrates how HitGen Inc. A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
HitGen Inc. A Competitors by Total Liabilities
The table below lists competitors of HitGen Inc. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Reliance Power Limited
NSE:RPOWER
|
India | ₹250.71 Billion |
|
Nexteer Automotive Group Limited
PINK:NTXVF
|
USA | $1.45 Billion |
|
Cpi Property Group SA
XETRA:O5G
|
Germany | €12.70 Billion |
|
Tanco Holdings Bhd
KLSE:2429
|
Malaysia | RM145.49 Million |
|
Zhongnanhong Culture Group Co Ltd
SHE:002445
|
China | CN¥598.72 Million |
|
Pactiv Evergreen Inc
NASDAQ:PTVE
|
USA | $4.77 Billion |
|
CREDITACCESS GRAMEEN LIMITED
NSE:CREDITACC
|
India | ₹211.54 Billion |
|
Enghouse Systems Limited
PINK:EGHSF
|
USA | $247.35 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down HitGen Inc. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.78 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how HitGen Inc. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for HitGen Inc. A (2019–2024)
The table below shows the annual total liabilities of HitGen Inc. A from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥334.04 Million | -3.62% |
| 2023-12-31 | CN¥346.57 Million | +1.41% |
| 2022-12-31 | CN¥341.75 Million | -14.11% |
| 2021-12-31 | CN¥397.89 Million | -2.31% |
| 2020-12-31 | CN¥407.32 Million | +229.60% |
| 2019-12-31 | CN¥123.58 Million | -- |